Le stress peut exacerber les symptômes, mais n'est pas un facteur de risque direct.
StressPhéochromocytome
#4
L'âge influence-t-il le risque de phéochromocytome ?
Oui, le phéochromocytome est plus fréquent chez les adultes jeunes et d'âge moyen.
ÂgePhéochromocytome
#5
Les antécédents médicaux jouent-ils un rôle ?
Oui, des antécédents de tumeurs endocriniennes augmentent le risque de phéochromocytome.
Antécédents médicauxTumeurs endocriniennes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phéochromocytome : Questions médicales les plus fréquentes",
"headline": "Phéochromocytome : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phéochromocytome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2026-06-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phéochromocytome"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Paragangliome",
"url": "https://questionsmedicales.fr/mesh/D010235",
"about": {
"@type": "MedicalCondition",
"name": "Paragangliome",
"code": {
"@type": "MedicalCode",
"code": "D010235",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.580.625.650.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Phéochromocytome",
"alternateName": "Pheochromocytoma",
"code": {
"@type": "MedicalCode",
"code": "D010673",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Karel Pacak",
"url": "https://questionsmedicales.fr/author/Karel%20Pacak",
"affiliation": {
"@type": "Organization",
"name": "Section on Medical Neuroendocrinology, National Institute of Child Health and Human Development, NIH, Bethesda, Maryland."
}
},
{
"@type": "Person",
"name": "Graeme Eisenhofer",
"url": "https://questionsmedicales.fr/author/Graeme%20Eisenhofer",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine III, Carl Gustav Carus University Medical Centre, Dresden, Germany; Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetcherstrasse 74, 01307 Dresden, Germany."
}
},
{
"@type": "Person",
"name": "Felix Beuschlein",
"url": "https://questionsmedicales.fr/author/Felix%20Beuschlein",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine IV, University Hospital, LMU Klinikum, Ludwig Maximilian University of Munich, 80336 Munich, Germany."
}
},
{
"@type": "Person",
"name": "Jacques W M Lenders",
"url": "https://questionsmedicales.fr/author/Jacques%20W%20M%20Lenders",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands; Department of Medicine III, Carl Gustav Carus University Medical Centre, Dresden, Germany. Electronic address: jacques.lenders@radboudumc.nl."
}
},
{
"@type": "Person",
"name": "Houda Salhi",
"url": "https://questionsmedicales.fr/author/Houda%20Salhi",
"affiliation": {
"@type": "Organization",
"name": "Department of Endocrinology, Diabetology and Nutrition, University Hospital Hassan II; Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah; Epidemiology and Health Science Research Laboratory, Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah, Fez, Morocco."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Management of Pheochromocytomas and Paragangliomas.",
"datePublished": "2024-03-23",
"url": "https://questionsmedicales.fr/article/38944505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.suc.2024.02.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Surgical treatment of pheochromocytoma].",
"datePublished": "2023-11-11",
"url": "https://questionsmedicales.fr/article/37968950",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14341/probl13283"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Metastatic risk factors in pheochromocytoma/paraganglioma].",
"datePublished": "2023-10-04",
"url": "https://questionsmedicales.fr/article/38796759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14341/probl13331"
}
},
{
"@type": "ScholarlyArticle",
"name": "Secondary diabetes mellitus in pheochromocytomas and paragangliomas.",
"datePublished": "2023-09-20",
"url": "https://questionsmedicales.fr/article/37731140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12020-023-03492-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Fulminant hypercorticism due to ACTG producing pheochromocytoma].",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/39069773",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14341/probl13374"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://questionsmedicales.fr/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du tissu nerveux",
"item": "https://questionsmedicales.fr/mesh/D009380"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs neuroectodermiques",
"item": "https://questionsmedicales.fr/mesh/D017599"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tumeurs neuroendocrines",
"item": "https://questionsmedicales.fr/mesh/D018358"
},
{
"@type": "ListItem",
"position": 7,
"name": "Paragangliome",
"item": "https://questionsmedicales.fr/mesh/D010235"
},
{
"@type": "ListItem",
"position": 8,
"name": "Phéochromocytome",
"item": "https://questionsmedicales.fr/mesh/D010673"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phéochromocytome - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phéochromocytome",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-31",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phéochromocytome",
"description": "Comment diagnostiquer un phéochromocytome ?\nQuels examens d'imagerie sont utilisés ?\nQuels sont les signes cliniques à surveiller ?\nPeut-on détecter un phéochromocytome par génétique ?\nQuel rôle joue le dosage des métanéphrines ?",
"url": "https://questionsmedicales.fr/mesh/D010673#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phéochromocytome",
"description": "Quels sont les symptômes principaux du phéochromocytome ?\nComment se manifestent les crises hypertensives ?\nLe phéochromocytome cause-t-il des troubles anxieux ?\nY a-t-il des symptômes atypiques ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D010673#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phéochromocytome",
"description": "Peut-on prévenir le phéochromocytome ?\nLes personnes à risque doivent-elles être surveillées ?\nY a-t-il des habitudes à éviter ?\nLes examens réguliers sont-ils recommandés ?\nLes maladies génétiques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D010673#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phéochromocytome",
"description": "Quel est le traitement principal du phéochromocytome ?\nDes médicaments sont-ils utilisés avant la chirurgie ?\nQuelles sont les options de traitement après la chirurgie ?\nLe phéochromocytome peut-il récidiver ?\nY a-t-il des traitements non chirurgicaux ?",
"url": "https://questionsmedicales.fr/mesh/D010673#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phéochromocytome",
"description": "Quelles complications peuvent survenir ?\nLe phéochromocytome peut-il affecter le cœur ?\nY a-t-il un risque accru d'accident vasculaire cérébral ?\nDes complications psychologiques sont-elles possibles ?\nLe phéochromocytome peut-il entraîner des complications métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D010673#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Phéochromocytome",
"description": "Quels sont les facteurs de risque du phéochromocytome ?\nLes maladies génétiques augmentent-elles le risque ?\nLe stress est-il un facteur de risque ?\nL'âge influence-t-il le risque de phéochromocytome ?\nLes antécédents médicaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D010673#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un phéochromocytome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins et urinaires pour mesurer les catécholamines."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les examens comme l'IRM ou le scanner abdominal permettent de visualiser la tumeur."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques à surveiller ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des épisodes de hypertension, palpitations et sueurs excessives."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un phéochromocytome par génétique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des prédispositions héréditaires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le dosage des métanéphrines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dosage des métanéphrines urinaires est un test clé pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du phéochromocytome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des crises d'hypertension, des maux de tête et des palpitations."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les crises hypertensives ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par des pics de pression artérielle, souvent accompagnés de sueurs."
}
},
{
"@type": "Question",
"name": "Le phéochromocytome cause-t-il des troubles anxieux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'augmentation des catécholamines peut provoquer de l'anxiété et des palpitations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes atypiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales ou des nausées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les jeunes adultes et les enfants."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le phéochromocytome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi génétique peut aider."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents familiaux doivent être surveillées régulièrement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et le stress peut aider à réduire les symptômes associés."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques comme la néoplasie endocrinienne multiple augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du phéochromocytome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la chirurgie pour retirer la tumeur surrénalienne."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils utilisés avant la chirurgie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antihypertenseurs sont souvent prescrits pour contrôler la pression artérielle."
}
},
{
"@type": "Question",
"name": "Quelles sont les options de traitement après la chirurgie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après la chirurgie, un suivi régulier et des traitements symptomatiques peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Le phéochromocytome peut-il récidiver ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive, nécessitant un suivi à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non chirurgicaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements non chirurgicaux comme la radiothérapie peuvent être envisagés dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des crises hypertensives sévères et des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Le phéochromocytome peut-il affecter le cœur ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des arythmies et des cardiomyopathies dues à l'hypertension."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru d'accident vasculaire cérébral ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hypertension chronique augmente le risque d'accident vasculaire cérébral."
}
},
{
"@type": "Question",
"name": "Des complications psychologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent survenir en raison des symptômes chroniques."
}
},
{
"@type": "Question",
"name": "Le phéochromocytome peut-il entraîner des complications métaboliques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des troubles métaboliques comme le diabète secondaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du phéochromocytome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, certaines maladies génétiques et l'âge."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des syndromes comme la néoplasie endocrinienne multiple augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, mais n'est pas un facteur de risque direct."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de phéochromocytome ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le phéochromocytome est plus fréquent chez les adultes jeunes et d'âge moyen."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de tumeurs endocriniennes augmentent le risque de phéochromocytome."
}
}
]
}
]
}
Department of Medicine III, Carl Gustav Carus University Medical Centre, Dresden, Germany; Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetcherstrasse 74, 01307 Dresden, Germany.
Department of Internal Medicine IV, University Hospital, LMU Klinikum, Ludwig Maximilian University of Munich, 80336 Munich, Germany.
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091 Zurich, Switzerland.
Department of Internal Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands; Department of Medicine III, Carl Gustav Carus University Medical Centre, Dresden, Germany. Electronic address: jacques.lenders@radboudumc.nl.
Department of Endocrinology, Diabetology and Nutrition, University Hospital Hassan II; Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah; Epidemiology and Health Science Research Laboratory, Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah, Fez, Morocco.
Department of Endocrinology, Diabetology and Nutrition, University Hospital Hassan II; Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah; Epidemiology and Health Science Research Laboratory, Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah, Fez, Morocco.
Department of Surgery, University of Pennsylvania Health System, 3400 Spruce Street, 4th Floor, Maloney Building, Philadelphia, PA 19104, USA; Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, 1600 Southwest Archer Road, Suite H-2, Gainesville, FL 32608, USA.
Department of Medicine, Division of Endocrinology, University of Florida, Malcom Randall VA Medical Center, Gainesville, FL 32610, USA. Electronic address: hans.ghayee@medicine.ufl.edu.
Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetcherstrasse 74, 01307 Dresden, Germany.
Department of Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France and European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.
University of Colorado School of Medicine, Department of Medicine, Division of Endocrinology, Metabolism and Diabetes and the Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, Colorado, USA.
Medizinische Klinik I, Lehrstuhl für Endokrinologie und Diabetologie, Universitätsklinik Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, OX3 7LE, UK; Centre for Endocrinology, Barts and the London School of Medicine, London, EC1M 6BQ, UK; ENETS Centre of Excellence, Royal Free Hospital, London, NW3 2QG, UK.
Department of Internal Medicine IV, University Hospital, LMU Klinikum, Ludwig Maximilian University of Munich, 80336 Munich, Germany.
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091 Zurich, Switzerland.
Pheochromocytomas and paragangliomas are distinctive neuroendocrine tumors which frequently produce excess catecholamines with resultant cardiovascular morbidity. These tumors have a strong genetic co...
This review article contains a summary of modern aspects of preoperative preparation, surgical treatment, and follow-up of patients with adrenal pheochromocytomas. The main component of preoperative p...
Currently, all pheochromocytoma/paraganglioma (PPGLs) are considered malignant due to metastatic potential. Consequently, PPGLs are divided into «metastatic» and «non-metastatic». Metastatic PPGLs can...
Secondary diabetes mellitus (DM) in secretory pheochromocytomas and paragangliomas (PPGLs) is encountered in up to 50% of cases, with its presentation ranging from mild, insulin resistant forms to pro...
Endogenous hypercorticism (EH) is a severe symptom complex caused by hypercortisolemia; according to the etiology, ACTH-dependent and ACTH-independent variants are distinguished, which, according to t...
Pheochromocytomas and paragangliomas (PPGLs) are rare neoplasms producing catecholamines that occur as hereditary syndromes in 25-40% of cases. To date, PPGLs are no longer classified as benign and ma...
Pheochromocytoma is a chromaffin cell-derived adrenal medullary tumour and usually presents with paroxysms of hypertension, palpitations, sweating and headache due to excessive catecholamine release. ...
Indocyanine green (ICG) fluorescence is a new intraoperative imaging modality for adrenal tumors. Previous work suggested that pheochromocytomas did not show fluorescence, but experience is limited. T...
This was an IRB-approved retrospective study. Patients who underwent adrenalectomy with ICG imaging were identified from a departmental database. Intraoperative fluorescence patterns were analyzed by ...
Of the 46 pheochromocytomas included, 50% (n = 23) exhibited fluorescence. Parameters predicting fluorescence on univariate analysis were age, tumor size and hereditary. On multivariate analysis, tumo...
This is the largest cohort to date assessing fluorescence properties of pheochromocytomas. In contrast to previous studies, we demonstrated that smaller pheochromocytomas do exhibit fluorescence. This...
Hypertensive crises in pediatric patients are rare conditions. However, determining their precise prevalence is more challenging than in adults due to the heterogeneity in the definition itself. These...
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that commonly produce excess catecholamines causing significant morbidity and mortality. Patients with cyanotic congenital h...
Advances in molecular genetics have provided new insights into a variety of germline mutations and somatic mutations related to PPGLs. In the CCHD population, mutations can occur in the hypoxia signal...